| Application no. and date | 16166492.5 (espacenet) (Federated) (European Patent Register), 20050808 | | Patent/reg. no. and date | DK/EP 3101026, 20180328 | | Publication date | 20161207 | | Priority no. and date | US 599401 P, 20040806, US 610001 P, 20040914, US 106879, 20050414 | | EP pub. no. and date |
EP 3101026 20161207 | | Effective date | | | Applicant/owner | Onyx Therapeutics, Inc., 249 E. Grand Avenue
South San Francisco, CA 94080, US | | Applicant ref. no. | T5714_DK | | Inventor | LAIDIG, Guy J., 329 Waverley Street
Menlo Park, CA 94025, US,
Smyth, Mark S., 700 East 19th Avenue
Apt. 211
San Mateso, CA 94403, US | | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | | Opponent | | | IPC Class | C07K 5/087 (2006.01) | | Title | FORBINDELSER TIL PROTEASOMENZYMHÆMNING | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
